Impact of sodium-glucose cotransporter-2 inhibitors on kidney outcomes in type 2 diabetes: A tertiary center experience

• Main Authors: Mohammed H Tawhari (Author), Raed A Aldahash (Author), Faisal M Almutairi (Author), Mahdi S Albogami (Author), Ahmad E Rokon (Author), Faisal A Alsomali (Author), Khaled H Alanazi (Author), Abdulrahman A Alshehri (Author), Talal H Almutairi (Author), Abdulrahman D Alharbi (Author), Rayan M Alghamdi (Author), Ibrahim H Tawhari (Author), Salih A Bin Salih (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BACKGROUND: Diabetic nephropathy (DN) is a complication of chronic hyperglycemia associated with diabetes mellitus (DM). Several studies have demonstrated the positive impact of sodium-glucose cotransporter-2 (SGLT2) inhibitors on kidney outcomes. The objective of the study was to evaluate the effec...